drugIndia
Cart
Glipament MV 1 Tablet ER

Glipament MV 1 Tablet ER

Glimepiride (1mg) + Voglibose (0.3mg) + Metformin (500mg)

Megmento Pharmaceutical Pvt Ltd
Anxiety disorder
88.00110.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 56%
Best Alternative100% Match

Glipohix 513 Tablet SR

Triohix Critical Care

Voglibose 0.3mg
Glipohix 513 Tablet SR

Pack Size

1 units

Price

38.4020% off
Glipohix 513 Tablet SR is 100% same as Glipament MV 1 Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹50

that's 56% off!

composition
  1. Voglibose 0.3mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
88.0020% OFF
110.00

About This Medicine

Product description & overview

Glipament MV 1 Tablet ER: A Comprehensive Blood Sugar Management Solution

Glipament MV 1 Tablet ER combines the effectiveness of three key ingredients to provide comprehensive blood sugar management:

* Glimepiride (1mg): A sulfonamide derivative that stimulates insulin release, helping lower blood glucose levels.
* Metformin (500mg): A biguanide drug known for its glucose-lowering effects on the liver and kidneys.
* Voglibose (0.3mg): A unique α-glucosidase inhibitor that prevents starch from being rapidly absorbed into the bloodstream, further aiding blood sugar control.

The combination of these three active components makes Glipament MV 1 Tablet ER a reliable choice for individuals with type 2 diabetes who require a potent and targeted approach to managing their glucose levels. It's essential to consult with a healthcare professional before taking any medication, as this may not be suitable for all individuals.

Important Note: This description is intended for informational purposes only and should not be construed as medical advice. Always follow the guidance of your healthcare provider regarding dosage and use.

Active composition

Glimepiride 1 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Voglibose0.3 mg
Metformin500 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glipament MV 1 Tablet ER.

High Risk

Pregnancy

Glipament MV 1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glipament MV 1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glipament MV 1 Tablet ER may be needed. Please consult your doctor. Glipament MV 1 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glipament MV 1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glipament MV 1 Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glipament MV 1 Tablet ER is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glipament MV 1 Tablet ER

Products matching your search